Skip to main content

Table 1 Clinical and demographic characteristics of patients with rheumatoid arthritis

From: Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis

 

RA patients

n = 37

Age, years

53 ± 10

   (range)

(28-76 years)

Sex, male/female

7/30

Radiological data, erosive/non-erosive

35/2

Rheumatoid factor, +/-

33/4

Duration of the disease, years ± SD

8 ± 6

Treatment

 

   Methotrexate/other

35/2*

   Previous anti-TNF, yes/no

37/0

   Previous anti-CD20, yes/no

13/24**

   Time after previous anti-CD20, month

22 ± 11

(6-61 months)

  1. * other, 1 chlorambucil, 1 azatioprin.
  2. ** One patient is included in both groups i.e. started as non-treated, then returned and was included as treated.
  3. Values are given as mean ± standard deviation (SD). RA = rheumatoid arthritis.